Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001380974 | SCV001579211 | pathogenic | Congenital myasthenic syndrome 2A | 2023-11-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ala295Leufs*66) in the CHRNB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHRNB1 are known to be pathogenic (PMID: 10562302). This variant is present in population databases (rs780391043, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with CHRNB1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1069201). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV003136054 | SCV003818620 | likely pathogenic | not provided | 2021-11-23 | criteria provided, single submitter | clinical testing |